Seike Yoshimasa, Matsuda Hitoshi, Fukuda Tetsuya, Inoue Yosuke, Omura Atsushi, Uehara Kyokun, Sasaki Hiroaki, Kobayashi Junjiro
Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565, Japan.
Department of Radiology, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565, Japan.
Gen Thorac Cardiovasc Surg. 2018 May;66(5):263-269. doi: 10.1007/s11748-018-0894-1. Epub 2018 Jan 31.
This study aimed to reveal the differences in intermediate outcomes between TAR and d-TEVAR in octogenarians and to identify risk factors for adverse events after aortic arch repair in octogenarians.
We reviewed medical records of 125 patients aged > 80 years who underwent surgical intervention for aortic aneurysm between 2008 and 2016. Of these, 60 underwent conventional TAR (43 men; age, 82 ± 2.2 years) and 65 underwent d-TEVAR (49 men; age, 84 ± 3.4 years).
Freedom from all causes of mortality at 2 and 4 years was similar (80 and 66% in TAR, 80 and 51% in d-TEVAR, p = 0.17). Freedom from aortic death at 2 and 4 years was similar (88 and 88% in TAR, 87 and 76% in d-TEVAR, p = 0.86). Using Cox regression analysis, chronic obstructive pulmonary disease (COPD) [hazard ratio (HR), 6.0; p = 0.008], malignancy (HR, 8.8; p = 0.004), previous cardiac and thoracic aortic surgery (required median sternotomy) (HR, 65.9; p = 0.012), perioperative stroke (HR, 12.6; p = 0.012), and postoperative pneumonia (HR, 5.8; p = 0.026) were identified as independent positive predictors of overall postoperative mortality for TAR, whereas neurological dysfunction (HR, 3.0; p = 0.016) and perioperative stroke (HR, 12.1; p = 0.023) were identified for d-TEVAR.
TAR in octogenarians with COPD and/or malignancy showed higher mortality rates; d-TEVAR is more appropriate in these situations. The prevention of perioperative stroke, which is related with poor prognosis in both the groups, is critical.
本研究旨在揭示80岁及以上老人接受全弓置换术(TAR)和降主动脉腔内修复术(d-TEVAR)后的中期结果差异,并确定80岁及以上老人主动脉弓修复术后不良事件的风险因素。
我们回顾了2008年至2016年间125例年龄大于80岁接受主动脉瘤手术干预患者的病历。其中,60例接受传统TAR(43例男性;年龄82±2.2岁),65例接受d-TEVAR(49例男性;年龄84±3.4岁)。
2年和4年时全因死亡率无差异(TAR组分别为80%和66%,d-TEVAR组分别为80%和51%,p = 0.17)。2年和4年时主动脉相关死亡率无差异(TAR组分别为88%和88%,d-TEVAR组分别为87%和76%,p = 0.86)。使用Cox回归分析,慢性阻塞性肺疾病(COPD)[风险比(HR),6.0;p = 0.008]、恶性肿瘤(HR,8.8;p = 0.004)、既往心脏和胸主动脉手术(需正中开胸)(HR,65.9;p = 0.012)、围手术期卒中(HR,12.6;p = 0.012)和术后肺炎(HR,5.8;p = 0.026)被确定为TAR术后总体死亡率的独立阳性预测因素,而神经功能障碍(HR,3.